Ceryvyn Therapeutics-ADRCYVNY
13F holders, Q3 2024 (September 30)7holders −2
3new positions
5sold out
1famous investor
$4.07avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding Ceryvyn Therapeutics-ADR (CYVNY) in their 13F filings, down 2 from Q2 2024. 3 opened new positions and 5 sold out. The largest holders were Regal Partners Ltd ($11.8M), Baker Bros. Advisors LP ($8.8M) and Millennium Management ($274K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Ceryvyn Therapeutics-ADR
- Filed as
- OPTHEA LTD (Q3 2024)
- CUSIP
- 68386J208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $204K |
| Exits | 5 | $2.3M |
All 13F filers, Q2 2024 → Q3 2024: 49,876 shares bought and 1,168,584 shares sold, net −1,118,708 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Regal Partners Ltd | 1.05% | No change | 2,907,403 | $11.8M |
| Baker Bros. Advisors LP | 0.09% | No change | 2,173,622 | $8.8M |
| Millennium Management | 0.00% | Reduce -5.3% | 67,392 | $274K |
| Stratos Wealth Partners, LTD. | 0.00% | Add +3.7% | 29,600 | $120K |
| Jane Street Group, LLC | 0.00% | New | 26,632 | $114K |
| Twin Lakes Capital Management, LLC | 0.05% | New | 19,806 | $81K |
| UBS Group AG | 0.00% | New | 2,388 | $10K |
"% of holder's portfolio" is CYVNY's weight in each manager's 13F, not the share of Ceryvyn Therapeutics-ADR the manager owns.